1. Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma. Issue 4 (21st March 2022) Authors: Halwani, Ahmad S.; Panizo, Carlos; Isufi, Iris; Herrera, Alex F.; Okada, Craig Y.; Cull, Elizabeth H.; Kis, Bela; Chaves, Jorge M.; Bartlett, Nancy L.; Ai, Weiyun; de la Cruz-Merino, Luis; Bryan, Locke J.; Houot, Roch; Linton, Kim; Briones, Javier; Chau, Ian; von Keudell, Gottfried R.; Lu, Hailin... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 4(2022) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗